All Wars Require Regime Change
There's an Indie Insurgency Brewing in Red States, and It Could Screw the...
Airport Nightmares Over TSA Lines Have Returned
Pete Hegseth Just Said This About Putting Troops on the Ground In Iran
FBI Just Took Huge Action Against ISIS-Inspired NYC Bombers
James Talarico Claims to Love 'Trans Children.' Here's How You Know He Doesn't.
Trump Gets Surprising Boost As New Poll Flips 2026 Narrative on Its Head
Feds Issue Warning After Alarming Intel About Iranian Sleeper Cells
ISIS-Inspired NYC Terrorists Formally Charged, Offer Startling Admission to Police
The Left Has a Newfound Respect for Religious Freedom, but Only When It's...
We're Learning More About the Alleged ISIS-Inspired NYC Bomb Throwers
California Is Inching Closer to the Possibility of Electing a Republican Governor
Leftist Protester Says 'We Want Everyone Here to Stay' Moments Before Terrorist Threw...
Trump Says He Is 'Nowhere Near' Deploying Ground Forces in Operation Epic Fury
Seriously? This Is What Jake Tapper Is Concerned About Right Now in Iran?
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement